Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $117,588 - $160,529
-285 Reduced 66.59%
143 $60,000
Q2 2022

Aug 05, 2022

SELL
$463.67 - $597.16 $168,312 - $216,769
-363 Reduced 45.89%
428 $212,000
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $190,418 - $266,957
363 Added 84.81%
791 $446,000
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $303,383 - $340,123
428 New
428 $323,000
Q1 2021

May 17, 2021

SELL
$547.01 - $662.35 $10,940 - $13,247
-20 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$510.68 - $643.45 $10,213 - $12,869
20 New
20 $12,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.